FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DUBERSTEIN GARY K
2. Issuer Name and Ticker or Trading Symbol

BIOTIME INC [ BTIM ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

150 E. 57TH STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

12/31/2008
(Street)

NEW YORK, NY 10022
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

1/8/2009 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares, no par value   12/31/2008   (1)   J    191163   D   (1) 407184   (2) I   By Greenway Partners, LP  
Common Shares, no par value                  12256   D    
Common Shares, no par value                  2076698   (3) I   By Greenbelt Corp.  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants   $2.00   12/31/2008   (1)         143168      (1) 10/31/2010   Common Shares   143168     (1) 347580   I   By Greenway Partners, LP  
Warrants   $2.00                   1/21/2004   10/31/2010   Common Shares   680     680   D    
Warrants   $2.00                   1/21/2004   10/31/2010   Common Shares   72604     72604   I   By Greenbelt Corp.  
Warrants   $2.00                   12/21/2005   10/31/2010   Common Shares   262028     262028   I   By Greenbelt Corp.  

Explanation of Responses:
( 1)  On December 31, 2008, Greenway Partners began distributing to its limited partners, on a pro rata basis, 191,163 Common Shares and 143,168 Warrants. The number of shares and warrants distributed to the Greenway limited partners reported in this amendment corrects the amounts previously reported in the Form 4 filed January 8, 2009, which inadvertently double counted the number of shares and warrants distributed to one limited partner.
( 2)  Does not include shares that Greenway may acquire at a price of $1.50 per share in exchange for a BioTime promissory note in the principal amount of $204,154, plus accrued interest thereon.
( 3)  Does not include shares that Greenbelt may acquire at a price of $1.75 per share in exchange for a BioTime promissory note in the principal amount of $100,000, plus accrued interest thereon.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DUBERSTEIN GARY K
150 E. 57TH STREET
NEW YORK, NY 10022

X


Signatures
/s/ Gary K. Duberstein 4/16/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Boatim (CE) (USOTC:BTIM)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Boatim (CE).
Boatim (CE) (USOTC:BTIM)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Boatim (CE).